This study is testing if a treatment called transcranial direct current stimulation (tDCS) can help reduce seizures in people with focal epilepsy, generalized onset epilepsy, or sleep-related epileptic encephalopathy. tDCS involves applying a small electrical current to the scalp using a device called ActivaDose II. Participants will receive either a 0.1 mA or 2.0 mA stimulation daily for two months, with each session lasting about 30 minutes. The main goal is to see if this treatment can lower the number of seizures you experience. To join, you must be at least 6 years old, have at least two seizures per month or a high spike-wave index (a measure from an EEG), and your current seizure medicines haven't fully controlled your seizures. The study is currently unclear on its recruitment status.

Study design

This is an interventional study with 30 planned participants. It is testing two different levels of electrical stimulation (0.1 mA and 2.0 mA).

What's involved

You would receive daily electrical stimulation treatments for two months, with each session lasting about 30 minutes. You would also need to maintain a constant medication schedule during the study.

Compensation

Not stated in the trial record.

Follow-up

The main outcome of the study, seizure count, will be measured at 2 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.